Optimal Management of Constipation in Adults
Start with a trial of polyethylene glycol (PEG) 17 grams once or twice daily as first-line pharmacological therapy, after attempting a gradual increase in dietary fiber to 25-30 grams daily for those with mild symptoms or inadequate dietary fiber intake 1, 2.
Stepwise Treatment Algorithm
Step 1: Dietary Modifications (Mild Constipation)
Specific food recommendations with evidence 3:
- Kiwifruits (2-3 daily)
- Prunes
- Rye bread
- High mineral-containing water (especially magnesium-rich)
Fluid intake: Only increase if baseline intake is low (lowest quartile of daily consumption); chronically constipated patients typically drink similar amounts as non-constipated individuals 1
Common pitfall: Fiber supplementation causes flatulence and may worsen symptoms in severe constipation or outlet dysfunction. The evidence for fiber is low quality, based on 30-40 year old studies with small sample sizes 1.
Step 2: First-Line Pharmacological Therapy
PEG (polyethylene glycol) is the recommended first-line agent 1:
- Dose: 17-17.5 g once or twice daily dissolved in water
- Strong recommendation with moderate certainty of evidence 1
- Durable response demonstrated over 6 months 1
- Side effects: abdominal distension, loose stool, flatulence, nausea 1
Can combine PEG with fiber supplement or use PEG alone if fiber trial fails 1.
Step 3: Alternative Laxatives if PEG Insufficient
- Magnesium oxide (5 recommendation statements with evidence) 3
- Stimulant laxatives (senna) - use temporarily, not as monotherapy 1, 4
- Probiotics (20 recommendation statements, though evidence quality varies) 3
Step 4: Specialized Assessment if Basic Treatment Fails
Perform physiological testing when patients fail available laxatives 5:
- Anorectal physiology tests 6
- Colorectal transit time assessment 6
- Defecography (barium or MRI) if symptoms suggest structural disorder 6
Key distinction: Differentiate between "decreased frequency" type versus "difficult defecation" type to guide therapy 4.
Step 5: Advanced Therapies
- Biofeedback therapy for dyssynergic defecation (proven effective) 6
- Newer agents for refractory cases:
- Rectal therapies: suppositories, enemas, transanal irrigation for evacuation disorders 6, 4
- Surgery: restricted to severe refractory cases only 6
Critical Evidence Considerations
The 2023 AGA-ACG guideline 1 provides the strongest recommendation for PEG with moderate certainty evidence from multiple RCTs including 304+ participants. This supersedes older approaches that emphasized fiber as primary therapy, which has only low-quality evidence from small, dated studies.
The 2025 British Dietetic Association guidelines 3 represent the most comprehensive dietary evidence (75 RCTs), but most recommendations carry very low to low evidence quality (51 of 59 statements). Only 8 recommendations achieved moderate evidence.
The evidence hierarchy clearly favors PEG over fiber for pharmacological management, though fiber remains reasonable for mild symptoms or as adjunctive therapy 1.